Bicalieva 50mg Tablet

About

Bicalieva 50mg Tablet contains bicalutamide, a non-steroidal anti-androgen that functions by blocking the action of androgens (male hormones) in the body. It is primarily utilized in the management of prostate cancer, often administered in conjunction with luteinizing hormone-releasing hormone (LHRH) analogues or following surgical castration. By inhibiting the binding of androgens to their receptors within prostate cancer cells, bicalutamide effectively slows down the growth and proliferation of hormone-sensitive prostate cancer. Its targeted mechanism on androgen receptors makes it a crucial component of combined androgen blockade therapy, aiming to achieve maximal androgen suppression and disease control.

This medication is absorbed orally and undergoes hepatic metabolism. Its long half-life allows for once-daily dosing, contributing to patient convenience and adherence. Regular monitoring of prostate-specific antigen (PSA) levels and liver function tests is essential during treatment to assess efficacy and safety. Bicalieva is a cornerstone in the systemic treatment of advanced prostate cancer, offering significant clinical benefits by mitigating the hormonal drive for tumor progression.

Uses

• Treatment of advanced prostate cancer.
• Used in combination with LHRH analogues.
• Adjuvant therapy after radical prostatectomy or radiotherapy.
• Management of hormone-sensitive prostate cancer.

Directions For Use

Take this tablet orally, usually once daily, with or without food, as directed by your physician.

Benefits

• Slows prostate cancer progression.
• Reduces tumor growth.
• Improves disease-free survival.
• Effective in combined androgen blockade.
• Helps manage symptoms of advanced prostate cancer.
• Oral administration for convenience.

Side Effects

• Hot flashes
• Breast tenderness
• Gynecomastia
• Nausea
• Diarrhea
• Constipation
• Fatigue
• Dizziness
• Hair thinning
• Liver enzyme elevation
• Anemia
• Peripheral edema

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it may increase the risk of liver problems, a potential side effect of bicalutamide.
• Pregnancy - Bicalieva is contraindicated in women and should not be used during pregnancy due to potential harm to a developing fetus.
• Breastfeeding - Bicalieva is not indicated for use in women, and therefore, breastfeeding considerations do not apply.
• Liver - Use with caution in patients with pre-existing liver impairment; regular monitoring of liver function tests is recommended.
• Kidney - Generally considered safe for use in patients with kidney conditions, but caution is advised in severe renal impairment.
• Lung - No specific contraindications or major concerns regarding lung conditions, but monitor for any unusual respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.